Patent US4742049A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4742049A Expired / Lapsed US ⏱️ 0.0 years remaining

Semisynthetic erythromycin antibiotics

Assignee: Abbott Laboratories
•
Filing: 1986-06-04
•
Granted: 1988-05-03
•
Expires: 2006-06-04
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Semisynthetic antibiotics with improved therapeutic properties made from erythromycin are disclosed. 11,12-Cyclic carbamates of erythromycin, its derivatives, and their salts and esters show superior in vitro antimicrobial activity and reduced hepatotoxicity compared to the parent compounds.

Inventors

  • 👤 William R. Baker
  • 👤 Jerry D. Clark

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-09 05:26
CPC Classifications
C; C07; C07H; C07H17/00; C07H17/04; C07H17/08; A; A61; A61P; A61P31/00; A61P31/04

Claims Analysis

Total Claims: 6
Claim 1
Independent Claim 42 words
A compound of the formula ##STR3## where R 1 is selected from hydroxyl or O-acyl of 2 to 20 carbon atoms, R 2 is hydrogen or methyl and R 3 is hydrogen, alkyl, alkoxy, dimethylaminoalkyl, or haloalkyl, and pharmaceutically acceptable salts thereof.
Claim 2
Dependent Claim 42 words
A compound of the formula ##STR3## where R 1 is selected from hydroxyl or O-acyl of 2 to 20 carbon atoms, R 2 is hydrogen or methyl and R 3 is hydrogen, alkyl, alkoxy, dimethylaminoalkyl, or haloalkyl, and pharmaceutically acceptable salts thereof.
Claim 3
Dependent Claim 11 words
A compound according to claim 1 wherein R 2 is methyl.
Claim 4
Dependent Claim 16 words
A compound according to claim 2 wherein R 1 is hydroxyl and R 3 is 2-dimethylaminoethyl.
Claim 5
Dependent Claim 25 words
An antibacterial composition in unit dosage form, comprising an antibacterially effective amount of a compound according to claim 1 in combination with a pharmaceutical carrier.
Claim 6
Dependent Claim 36 words
A method of treating and preventing bacterial infections in humans and lower animals in need of such treatment, comprising administering to the human or lower animal a therapeutically effective amount of the composition of claim 4.

References Cited (Backward Citations)

JPS5259086A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1991-05-03 1991-11-02 1992-05-03 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1995-05-03 1995-11-02 1996-05-03 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1999-05-03 1999-11-02 2000-05-03 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag